![Martin Kessler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Kessler
Algemeen Directeur bij DiNAMIQS
Profiel
Martin Kessler is currently the Chief Executive Officer at DiNAMIQS and the Chairman-Supervisory Board at Kessler & Co. AG.
He holds a doctorate degree from the Technical University of Berlin.
Actieve functies van Martin Kessler
Bedrijven | Functie | Begin |
---|---|---|
Kessler & Co. AG
![]() Kessler & Co. AG Life/Health InsuranceFinance Kessler & Co. AG provides risk management and insurance consulting services. It offers its clients customized risk analysis, modern risk financing concepts, and insurance solutions. The firm also provides legal consulting services and assistance with insurance claims. The company was founded in 1915 and is headquartered in Zurich, Switzerland. | Voorzitter | - |
DiNAMIQS
![]() DiNAMIQS BiotechnologyHealth Technology DiNAMIQS is a Swiss company that specializes in the development and manufacturing of viral vectors for cell and gene therapies. The private company is based in Schlieren, Switzerland. The CEO of the company is Eduard Ayuso. | Algemeen Directeur | 01-03-2024 |
Opleiding van Martin Kessler
Technical University of Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Kessler & Co. AG
![]() Kessler & Co. AG Life/Health InsuranceFinance Kessler & Co. AG provides risk management and insurance consulting services. It offers its clients customized risk analysis, modern risk financing concepts, and insurance solutions. The firm also provides legal consulting services and assistance with insurance claims. The company was founded in 1915 and is headquartered in Zurich, Switzerland. | Finance |
DiNAMIQS
![]() DiNAMIQS BiotechnologyHealth Technology DiNAMIQS is a Swiss company that specializes in the development and manufacturing of viral vectors for cell and gene therapies. The private company is based in Schlieren, Switzerland. The CEO of the company is Eduard Ayuso. | Health Technology |